Drug Interactions between Metoprolol Succinate ER and propylthiouracil
This report displays the potential drug interactions for the following 2 drugs:
- Metoprolol Succinate ER (metoprolol)
- propylthiouracil
Interactions between your drugs
metoprolol propylthiouracil
Applies to: Metoprolol Succinate ER (metoprolol) and propylthiouracil
MONITOR: The clearance of some beta-blockers with high extraction ratios may be reduced when a euthyroid state is achieved after the addition of antithyroid agents. Sotalol, nadolol, carteolol, and atenolol, which are primarily eliminated by the kidney, do not appear to be affected by changes in thyroid function.
MANAGEMENT: The patient should be closely monitored for altered efficacy and safety while achieving a euthyroid state or when the antithyroid agent dosage is added, discontinued, or changed. Beta blocker dose reductions may be required.
References (5)
- Hallengren B, Nilsson OR, Karlberg BE, Melander A, Tegler L, Wahlin-Boll E (1982) "Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol." Eur J Clin Pharmacol, 21, p. 379-84
- Feely J, Crooks J, Stevenson IH (1981) "Plasma propranolol steady state concentrations in thyroid disorders." Eur J Clin Pharmacol, 19, p. 329-33
- Feely J, Stevenson IH, Crooks J (1981) "Increased clearance of propranolol in thyrotoxicosis." Ann Intern Med, 94, p. 472-4
- Aro A, Anttila M, Korhonen T, Sundquist H (1982) "Pharmacokinetics of propranolol and sotalol in hyperthyroidism." Eur J Clin Pharmacol, 21, p. 373-7
- Feely J, Crooks J, Stevenson IH (1981) "The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration." Br J Clin Pharmacol, 12, p. 73-8
Drug and food interactions
metoprolol food
Applies to: Metoprolol Succinate ER (metoprolol)
ADJUST DOSING INTERVAL: The bioavailability of metoprolol may be enhanced by food.
MANAGEMENT: Patients may be instructed to take metoprolol at the same time each day, preferably with or immediately following meals.
References (2)
- (2001) "Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals
- Darcy PF (1995) "Nutrient-drug interactions." Adverse Drug React Toxicol Rev, 14, p. 233-54
metoprolol food
Applies to: Metoprolol Succinate ER (metoprolol)
ADJUST DOSING INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism of interaction is unknown. In six healthy subjects, calcium 500 mg (as lactate, carbonate, and gluconate) reduced the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of atenolol (100 mg) by 51% and 32%, respectively. The elimination half-life increased by 44%. Twelve hours after the combination, beta-blocking activity (as indicated by inhibition of exercise tachycardia) was reduced compared to that with atenolol alone. However, during a 4-week treatment in six hypertensive patients, there was no difference in blood pressure values between treatments. The investigators suggest that prolongation of the elimination half-life induced by calcium coadministration may have led to atenolol cumulation during long-term dosing, which compensated for the reduced bioavailability.
MANAGEMENT: It may help to separate the administration times of beta-blockers and calcium products by at least 2 hours. Patients should be monitored for potentially diminished beta-blocking effects following the addition of calcium therapy.
References (1)
- Kirch W, Schafer-Korting M, Axthelm T, Kohler H, Mutschler E (1981) "Interaction of atenolol with furosemide and calcium and aluminum salts." Clin Pharmacol Ther, 30, p. 429-35
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.